These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36830313)

  • 21. Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4.
    Palmeira A; Sousa E; Fernandes MX; Pinto MM; Vasconcelos MH
    J Pharm Pharm Sci; 2012; 15(1):31-45. PubMed ID: 22365086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro.
    Weiss J; Haefeli WE
    Cancer Chemother Pharmacol; 2011 Oct; 68(4):1093-8. PubMed ID: 21805352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic drug interactions with new oral anticoagulants: what do they mean for patients with atrial fibrillation?
    Hellwig T; Gulseth M
    Ann Pharmacother; 2013 Nov; 47(11):1478-87. PubMed ID: 24259602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2021 Oct; 49(10):910-918. PubMed ID: 34326138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.
    Talavera Pons S; Boyer A; Lamblin G; Chennell P; Châtenet FT; Nicolas C; Sautou V; Abergel A
    Br J Clin Pharmacol; 2017 Feb; 83(2):269-293. PubMed ID: 27530469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein.
    Lou Y; Guo Z; Zhu Y; Zhang G; Wang Y; Qi X; Lu L; Liu Z; Wu J
    J Ethnopharmacol; 2019 Jan; 228():82-91. PubMed ID: 30243825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
    Te Brake LH; Russel FG; van den Heuvel JJ; de Knegt GJ; de Steenwinkel JE; Burger DM; Aarnoutse RE; Koenderink JB
    Tuberculosis (Edinb); 2016 Jan; 96():150-7. PubMed ID: 26682943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice.
    Brzozowska N; Li KM; Wang XS; Booth J; Stuart J; McGregor IS; Arnold JC
    PeerJ; 2016; 4():e2081. PubMed ID: 27257556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lactic acid on drug-metabolizing enzymes in Chinese mitten crab (Eriocheir sisnensis) after oral enrofloxacin.
    Su H; Sun J; Fang S; Wei Y; Zheng R; Jiang Y; Hu K
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Sep; 223():9-14. PubMed ID: 31048018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Elimination of Enrofloxacin Under Varying Temperature and pH in Aquaculture Water: An Orthogonal Study.
    Fang L; Zhou Y; Huang Z; Yang G; Li T; Song C; Chen J
    Bull Environ Contam Toxicol; 2021 May; 106(5):866-872. PubMed ID: 33768336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of fluoroquinolone pharmacokinetic parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs.
    Frazier DL; Thompson L; Trettien A; Evans EI
    J Vet Pharmacol Ther; 2000 Oct; 23(5):293-302. PubMed ID: 11107003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Lempers VJ; van den Heuvel JJ; Russel FG; Aarnoutse RE; Burger DM; Brüggemann RJ; Koenderink JB
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3372-9. PubMed ID: 27001813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters.
    Gopaul VS; Vildhede A; Andersson TB; Erlandsson F; Lee CA; Johansson S; Hilgendorf C
    J Pharmacol Exp Ther; 2021 Aug; 378(2):108-123. PubMed ID: 34074714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and muscle tissue disposition of enrofloxacin in Nile tilapia (
    Corum O; Terzi E; Durna Corum D; Tastan Y; Gonzales RC; Kenanoglu ON; Arriesgado DM; Navarro VR; Bilen S; Sonmez AY; Uney K
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2022 Nov; 39(11):1806-1817. PubMed ID: 36136094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
    Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
    J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole).
    Kobayashi K; Abe Y; Kawai A; Furihata T; Endo T; Takeda H
    J Clin Pharmacol; 2020 Oct; 60(10):1314-1323. PubMed ID: 32459872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
    Weiss J; Sauer A; Divac N; Herzog M; Schwedhelm E; Böger RH; Haefeli WE; Benndorf RA
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):150-61. PubMed ID: 20222053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.
    Azam C; Claraz P; Chevreau C; Vinson C; Cottura E; Mourey L; Pouessel D; Guibaud S; Pollet O; Le Goff M; Bardies C; Pelagatti V; Canonge JM; Puisset F
    Eur J Clin Pharmacol; 2020 Apr; 76(4):579-587. PubMed ID: 31932871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residue, biotransformation, risk assessment and withdrawal time of enrofloxacin in red swamp crayfish (Procambarus clarkii).
    Liu Y; Ai X; Sun R; Yang Y; Zhou S; Dong J; Yang Q
    Chemosphere; 2022 Nov; 307(Pt 1):135657. PubMed ID: 35820477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.